PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2022-11-03

Date Title Company
03-Nov-2022 Vizgen Wins “Overall BioTech Company of the Year” in 2022 BioTech Breakthrough Awards Program Businesswire
03-Nov-2022 Exelixis and Catalent Enter into New License Agreement for Three Antibody-Drug Conjugate Programs with the Potential to Accelerate Exelixis’ Biologics Pipeline Businesswire
03-Nov-2022 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
03-Nov-2022 Angeles Equity Partners Portfolio Company RōBEX Acquires Vantage Corporation Businesswire
03-Nov-2022 Organon Reports Results for the Third Quarter Ended September 30, 2022 Businesswire
03-Nov-2022 Virios Therapeutics to Report Third Quarter 2022 Financial Results and Provide Corporate Update on Monday, November 14, 2022 Businesswire
03-Nov-2022 Ironwood Pharmaceuticals Reports Strong Third Quarter 2022 Results; Maintains Full Year 2022 Financial Guidance Businesswire
03-Nov-2022 Aura Biosciences to Participate in Upcoming Investor Conferences Businesswire
03-Nov-2022 Teva Reports Third Quarter 2022 Financial Results Businesswire
03-Nov-2022 Deciphera Pharmaceuticals, Inc. Announces Third Quarter 2022 Financial Results Businesswire
03-Nov-2022 Bicycle Therapeutics Reports Third Quarter 2022 Financial Results and Provides Corporate Update Businesswire
03-Nov-2022 Pyramid Biosciences to Present at the 2022 Jefferies London Healthcare Conference Businesswire
03-Nov-2022 Gurnet Point Capital Appoints Stacey Seltzer as Partner Businesswire
03-Nov-2022 Radiopharmaceuticals Global Market to Reach $7.3 Billion by 2026 at a CAGR of 5.5% - ResearchAndMarkets.com Businesswire
03-Nov-2022 AmerisourceBergen Reports Fiscal 2022 Fourth Quarter and Year End Results Businesswire
03-Nov-2022 Global Smoking Cessation & Nicotine De-Addiction Product Market to Reach $40.6 Billion by 2027 at a CAGR of 9.39% - ResearchAndMarkets.com Businesswire
03-Nov-2022 Latest Process Validation Guidance Requirements course (FDA and EU Annex 15: Qualifications and Validation) (November 7-8, 2022) - ResearchAndMarkets.com Businesswire
03-Nov-2022 MorphoSys to Share New Data on Pelabresib and Monjuvi® (tafasitamab-cxix) in 14 Presentations at the American Society of Hematology Annual Meeting MorphoSys AG
03-Nov-2022 Biodesix Announces Third Quarter 2022 Results and Highlights Businesswire
03-Nov-2022 MiGenTra Highlights How Biosimilars Are Transforming Healthcare in Africa at the Festival of Biologics B3C newswire